Management of chronic urticaria and angioedema
Standards of Care Committee, British Society for Allergy and Clinical Immunology
It is estimated that chronic urticaria affects 2–3% of individuals (lifetime prevalence) and significantly reduces quality of life. Diagnosis is based primarily on the clinical history. Optimal management of chronic and acute intermittent urticaria depends on a thorough understanding of clinical presentation, aetiology, triggers, and aggravating factors.
This Guidelines summary covers diagnosis and treatment, and also includes a management algorithm.